设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Elsevier电子期刊(221)
在“
Elsevier电子期刊
”中,
命中:
221
条,耗时:小于0.01 秒
在所有数据库中总计命中:
221
条
1.
Temsirolimus
induced structural transition of cancerous renal cystatin to normal form in rats: In vitro mechanistic approach underlying renal cancer prevention
作者:
Anas Shamsi
;
Azaj Ahmed
;
Bilqees Bano
;
bbbano17@gmail.com
关键词:
FTIR
;
Fourier transformed infrared spectroscopy
;
RKC
;
rat kidney cystatin
;
CRKC
;
cancerous rat kidney cystatin
;
CD
;
circular dichroism
;
DMN
;
dimethylnitrosamine
;
RCC
;
renal cell carcinoma
;
mRCC
;
metastatic renal cell carcinoma
;
mTOR
;
mechanistic target of rapamycin
刊名:International Journal of Biological Macromolecules
出版年:2017
2.
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
作者:
J. Connor Wells
a
;
b
;
Igor Stukalin
a
;
Craig Norton
c
;
Sandy Srinivas
d
;
Jae Lyun Lee
e
;
Frede Donskov
f
;
Georg A. Bjarnason
g
;
Haru Yamamoto
h
;
Benoit Beuselinck
i
;
Brian I. Rini
j
;
Jennifer J. Knox
k
;
Neeraj Agarwal
l
;
D. Scott Ernst
m
;
Sumanta K. Pal
n
;
Lori A. Wood
o
;
Aristotelis Bamias
p
;
Ajjai S. Alva
q
;
Ravindran Kanesvaran
r
;
Toni K. Choueiri
c
;
&dagger
;
;
Daniel Y.C. Heng
a
;
&dagger
;
;
daniel.heng@albertahealthservices.ca
关键词:
Metastatic renal cell carcinoma
;
Third line therapy
;
Targeted therapy
刊名:European Urology
出版年:2017
3.
mTOR inhibitor
temsirolimus
and MEK1/2 inhibitor U0126 promote chromosomal instability and cell type-dependent phenotype changes of glioblastoma cells
作者:
A.A. Stepanenko
a
;
a.a.stepanenko@gmail.com" class="auth_mail" title="E-mail the corresponding author
;
S.V. Andreieva
a
;
K.V. Korets
a
;
D.O. Mykytenko
a
;
V.P. Baklaushev
b
;
c
;
V.P. Chekhonin
b
;
V.V. Dmitrenko
a
;
1
关键词:
aCGH
;
Array comparative genome hybridization
;
CIN
;
Chromosomal instability
;
CCAs
;
Clonal chromosome aberrations
;
CNAs
;
Copy number alterations
;
EVE
;
Everolimus
;
MEK
;
Mitogen-activated and extracellular signal-regulated kinase kinase
;
mTOR
;
Mammalian target of rapamycin
;
NCCAs
;
Non-clonal chromosome aberrations
;
TEM
;
Temsirolimus
;
TMZ
;
Temozolomide
刊名:Gene
出版年:2016
4.
Temsirolimus
in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
作者:
Gü
;
nter Emons
a
;
emons@med.uni-goettingen.de" class="auth_mail" title="E-mail the corresponding author
;
Christian Kurzeder
b
;
c.kurzeder@kliniken-essen-mitte.de" class="auth_mail" title="E-mail the corresponding author
;
Barbara Schmalfeldt
c
;
1
;
b.schmalfeldt@uke.de" class="auth_mail" title="E-mail the corresponding author
;
Petra Neuser
d
;
Petra.Neuser@KKS.uni-marburg.de" class="auth_mail" title="E-mail the corresponding author
;
Nikolaus de Gregorio
e
;
Nikolaus.deGregorio@uniklinik-ulm.de" class="auth_mail" title="E-mail the corresponding author
;
Jacobus Pfisterer
f
;
2
;
jacobus.pfisterer@googlemail.com" class="auth_mail" title="E-mail the corresponding author
;
Tjoung-Won Park-Simon
g
;
park-simon.tjoung-won@mh-hannover.de" class="auth_mail" title="E-mail the corresponding author
;
Sven Mahner
h
;
3
;
Sven.Mahner@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author
;
Willibald Schrö
;
der
i
;
prof.schroeder@gynaekologicum-bremen.de" class="auth_mail" title="E-mail the corresponding author
;
Hans-Joachim Lü
;
ck
j
;
hlueck@goph.de" class="auth_mail" title="E-mail the corresponding author
;
Martin Leonhard Heubner
k
;
martin.heubner@uk-essen.de" class="auth_mail" title="E-mail the corresponding author
;
Lars Hanker
l
;
4
;
Lars.Hanker@uksh.de" class="auth_mail" title="E-mail the corresponding author
;
Falk Thiel
m
;
5
;
Falk.Thiel@af-k.de" class="auth_mail" title="E-mail the corresponding author
;
Felix Hilpert
n
;
felix.hilpert@gmail.com" class="auth_mail" title="E-mail the corresponding author
关键词:
Ovarian cancer
;
Endometrial cancer
;
Temsirolimus
;
mTOR inhibitor
;
Rapalog
刊名:Gynecologic Oncology
出版年:2016
5.
Ibrutinib versus
temsirolimus
in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
作者:
Prof Dr Martin Dreyling
;
MD
a
;
&dagger
;
;
Martin.Dreyling@med.uni-muenchen.de" class="auth_mail" title="E-mail the corresponding author
;
Wojciech Jurczak
;
MD
b
;
&dagger
;
;
Mats Jerkeman
;
MD
c
;
&dagger
;
;
Rodrigo Santucci Silva
;
MD
d
;
Chiara Rusconi
;
MD
e
;
&dagger
;
;
Prof Marek Trneny
;
MD
f
;
&dagger
;
;
Fritz Offner
;
MD
g
;
&dagger
;
;
Dolores Caballero
;
MD
h
;
&dagger
;
;
Prof Cristina Joao
;
MD
i
;
r
;
&dagger
;
;
Prof Mathias Witzens-Harig
;
MD
j
;
&dagger
;
;
Georg Hess
;
MD
k
;
&dagger
;
;
Isabelle Bence-Bruckler
;
MD
l
;
Prof Seok-Goo Cho
;
MD
m
;
John Bothos
;
PhD
n
;
Jenna D Goldberg
;
MD
n
;
Christopher Enny
;
BS
n
;
Shana Traina
;
PhD
n
;
Sriram Balasubramanian
;
PhD
o
;
Nibedita Bandyopadhyay
;
PhD
n
;
Steven Sun
;
PhD
n
;
Jessica Vermeulen
;
MD
p
;
Aleksandra Rizo
;
MD
n
;
Prof Simon Rule
;
MD
q
;
&dagger
;
刊名:The Lancet
出版年:2016
6.
Tumor mutational analysis of GOG248, a phase II study of
temsirolimus
or
temsirolimus
and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
作者:
Andrea P. Myers
a
;
andrea.myers@novartis.com" class="auth_mail" title="E-mail the corresponding author
;
Virginia L. Filiaci
b
;
Yuping Zhang
c
;
Michael Pearl
d
;
Kian Behbakht
e
;
Vicky Makker
f
;
Parviz Hanjani
g
;
Susan Zweizig
h
;
James J. Burke II
i
;
Gordon Downey
j
;
Kimberly K. Leslie
c
;
Paul Van Hummelen
a
;
Michael J. Birrer
k
;
Gini F. Fleming
l
刊名:Gynecologic Oncology
出版年:2016
7.
Commentary on: “Randomized phase III trial of
temsirolimus
and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.‿/span> Rini BI, Bellmunt J, Clancy J, Wang K, Niethammer AG, Hariharan S, Escudier B.
作者:
Donald Trump
;
M.D.
刊名:Urologic Oncology: Seminars and Original Investigations
出版年:2016
8.
Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data
作者:
Dr. Loay Kassem
a
;
loay.kassem@cairocure.com
;
Omar Abdel-Rahman
b
关键词:
Ovarian cancer
;
Endometrial cancer
;
Cervical cancer
;
Everolimus
;
Temsirolimus
刊名:Critical Reviews in Oncology/Hematology
出版年:2016
9.
Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma
作者:
Viktor Grü
;
nwald
a
;
Gruenwald.Viktor@mh-hannover.de" class="auth_mail" title="E-mail the corresponding author
;
Xun Lin
b
;
Daniel Kalanovic
c
;
Ronit Simantov
d
关键词:
Early tumour shrinkage
;
Overall survival
;
Predictive factor
;
Prognostic factor
;
Progression-free survival
;
Renal cell carcinoma
刊名:European Urology
出版年:2016
10.
Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease
作者:
S. Duarte-Silva
;
A. Silva-Fernandes
;
A. Neves-Carvalho
;
C. Soares-Cunha
;
A. Teixeira-Castro
;
P. Maciel
;
pmaciel@ecsaude.uminho.pt" class="auth_mail" title="E-mail the corresponding author
关键词:
EM
;
electron microscopy
;
FDA
;
Food and Drug Administration
;
HD
;
Huntington disease
;
LiCl
;
lithium chloride
;
MJD
;
Machado&ndash
;
Joseph disease
;
mTOR
;
mammalian target of rapamycin
;
NGM
;
nematode growth medium
;
polyQ
;
polyglutamine disorders
;
SCA
;
Spinocerebellar Ataxia type
;
wt
;
wild-type
刊名:Neuroscience
出版年:2016
1
2
3
4
5
6
7
8
9
按检索点细分(221)
题名(99)
关键词(77)
文摘(137)
按出版年细分(221)
2027年及以后(18)
2017年(2)
2016年(9)
2015年(5)
2013年(29)
2012年(30)
2011年(15)
2010年(17)
2009年(39)
2008年(34)
2007年(14)
2006年(6)
2005年(2)
2000年及以前(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.